Lifeway Foods shares fell 3.85% in afternoon trading to $26.20 after the company posted record quarterly revenue but faced immediate market pressure following disclosure of a deeply discounted secondary share sale by its largest institutional investor.
In the first quarter of 2026 Lifeway reported net sales of $63.0 million, a 37% year-over-year increase driven by higher volumes, led by its core kefir product line. Management also reported notable expansion in gross profit margins and net income that rose 32% over the comparable period.
Despite those operating gains, investor focus shifted to a secondary offering announced by Danone USA Public Benefit Corporation. Danone has priced 3,454,756 Lifeway shares at $19.50 per share, a material discount to Lifeway's prior closing price of $27.25. The block sale is scheduled to close on May 19, 2026.
The transaction will not involve Lifeway selling any shares, and the company will not receive proceeds from the offering. The move represents a notable development in the long-standing relationship between the two firms. Danone holds roughly a 23% stake in Lifeway, and the two companies have experienced a contentious dynamic in recent years as Lifeway resisted several acquisition attempts it judged to undervalue the business.
The pricing and size of Danone's secondary offering appear to have been the proximate cause of the share-price decline despite the company's positive quarterly performance. Market participants weighed the immediate dilution and the presence of a large block of stock being sold at a substantial discount, factors that can exert downward pressure on a company's market valuation even when operational metrics improve.
Investors will watch the closing of the offering on May 19, 2026, and any subsequent market reaction as the sale completes and shares change hands.